COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 1759: Articles 17581-17590  | Next

CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults
Veenith, T., Fisher, B. A., Slade, D., Rowe, A., Sharpe, R., Thickett, D. R., Whitehouse, T., Rowland, M., Scriven, J., Parekh, D., Bowden, S. J., Savage, J. S., Richards, D., Bion, J., Kearns, P., Gates, S., on behalf of CATALYST investigators
10.1101/2021.02.10.21251478 — Posted: 2021-02-15
A Comparative Analysis of COVID-19 Physical Distancing Policies in Botswana, India, Jamaica, Mozambique, Namibia, Ukraine, and the United States
Lane, J., Means, A., Bardosh, K., Shapoval, A., Vio, F., Anderson, C., Cushnie, A., Forster, N., Ledikwe, J., OMalley, G., Mawandia, S., Parvez, A., Perrone, L., Mudender, F.
10.1101/2021.02.09.21251433 — Posted: 2021-02-15
Demographic and Hygienic Factors as Predictors of Face Mask Wearing During Covid-19 Pandemic in Malaysia
Looi, K. H., Zhang, S. X., Li, N., Li, J.
10.1101/2021.02.09.21251280 — Posted: 2021-02-15
Mutation N501Y in RBD of Spike Protein Strengthens the Interaction between COVID-19 and its Receptor ACE2
Tian, F., Tong, B., Sun, L., Shi, S., Zheng, B., Wang, Z., Dong, X., Zheng, P.
10.1101/2021.02.14.431117 — Posted: 2021-02-15
Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures
Shen, Z., Ratia, K., Cooper, L., Kong, D., Lee, H., Kwon, Y., Li, Y., Alqarni, S., Huang, F., Dubrovskyi, O., Rong, L., Thatcher, G. R., XIONG, R.
10.1101/2021.02.13.431008 — Posted: 2021-02-15
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
Vandyck, K., Abdelnabi, R., Gupta, K., Jochmans, D., Jekle, A., Deval, J., Misner, D., Bardiot, D., Foo, C. S., Liu, C., Ren, S., Beigelman, L., Blatt, L. M., Boland, S., Vangeel, L., Dejonghe, S., Chaltin, P., Marchand, A., Serebryany, V., Stoycheva, A., Chanda, S., Symons, J. A., Raboisson, P., Neyts, J.
10.1101/2021.02.14.431129 — Posted: 2021-02-15 Discussion: Onsite
Deep learning models for COVID-19 chest x-ray classification: Preventing shortcut learning using feature disentanglement
Robinson, C., Trivedi, A., Blazes, M., Ortiz, A., Desbiens, J., Gupta, S., Dodhia, R., Bhatraju, P. K., Liles, W. C., Lee, A., Kalpathy-Cramer, J., Ferres, J. M. L.
10.1101/2021.02.11.20196766 — Posted: 2021-02-15
Risk of Corona virus disease 2019 (COVID-19) among spectacles wearing population of Northern India
Saxena, A. K.
10.1101/2021.02.12.21249710 — Posted: 2021-02-15 Discussion: Onsite
Evaluation of Facial Protection Against Close-Contact Droplet Transmission
Stephenson, T. B., Cumberland, C., Kibble, G., Church, C., Nogueira-Prewitt, S., MacNamara, S., Harnish, D. A., Heimbuch, B. K.
10.1101/2021.02.09.21251443 — Posted: 2021-02-15
Returning to nursing during the COVID-19 pandemic: experiences and needs of re-entering nurses
Noorland, S. A., Hoekstra, T., Kok, M. O.
10.1101/2021.02.11.21251571 — Posted: 2021-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).